- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-3170
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Vericiguat for Heart Failure with Reduced Ejection Fraction ; volume:23 ; number:10 ; day:19 ; month:8 ; year:2021 ; pages:1-7 ; date:10.2021
Current cardiology reports ; 23, Heft 10 (19.8.2021), 1-7, 10.2021
- Urheber
-
Lombardi, Carlo Mario
Cimino, Giuliana
Pagnesi, Matteo
Dell’Aquila, Andrea
Tomasoni, Daniela
Ravera, Alice
Inciardi, Riccardo
Carubelli, Valentina
Vizzardi, Enrico
Nodari, Savina
Emdin, Michele
Aimo, Alberto
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11886-021-01580-6
- URN
-
urn:nbn:de:101:1-2021122508005203475491
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lombardi, Carlo Mario
- Cimino, Giuliana
- Pagnesi, Matteo
- Dell’Aquila, Andrea
- Tomasoni, Daniela
- Ravera, Alice
- Inciardi, Riccardo
- Carubelli, Valentina
- Vizzardi, Enrico
- Nodari, Savina
- Emdin, Michele
- Aimo, Alberto
- SpringerLink (Online service)
Ähnliche Objekte (12)
SGLT2 inhibitors in heart failure with reduced ejection fraction
Heart Failure with Reduced Ejection Fraction—Does Sex Matter?
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection Fraction
Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
Association between class of foundational medication for heart failure and prognosis in heart failure with reduced/mildly reduced ejection fraction
SGLT2 inhibitors in heart failure with reduced ejection fraction
Heart Failure with Reduced Ejection Fraction—Does Sex Matter?
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection Fraction
Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
Association between class of foundational medication for heart failure and prognosis in heart failure with reduced/mildly reduced ejection fraction
SGLT2 inhibitors in heart failure with reduced ejection fraction
Heart Failure with Reduced Ejection Fraction—Does Sex Matter?
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection Fraction
Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction